Linden Thomas Advisory Services, LLC Exact Sciences Corp Transaction History

Linden Thomas Advisory Services, LLC

  • $732 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
SELL
$62.68 - $95.05 $3,134 - $4,752
-50 Reduced 0.97%
5,094 $478 Million
Q1 2023

Apr 24, 2023
BUY
$47.19 - $70.77 $18,640 - $27,954
395 Added 8.32%
5,144 $349 Million
Q4 2022

Feb 16, 2023
BUY
$30.35 - $53.15 $144,132 - $252,409
4,749 New
4,749 $235 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email